GlassScriptPhysician profile
Alejandra Y Angel
NPI 1326033655
$3,679.09
in general payments reported to CMS, 2019-2025
29 companies · $678 in 2025
The $678 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $298 · 2021: $579 · 2022: $979 · 2023: $390 · 2024: $639 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.15 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $509.08 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $450.78 | 2022-2025 | Veozah |
| Biogen, INC. | $364.07 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $332.19 | 2021-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $248.87 | 2019-2022 | |
| Medicem INC. | $232.71 | 2021-2023 | |
| Therapeuticsmd, INC. | $196.37 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $193.14 | 2021-2025 | |
| Coopersurgical, INC. | $186.59 | 2022-2025 | Onetrac Lx, Paragard T 380a, Paragard T 380a |
| Sage Therapeutics, LLC | $176.05 | 2020-2023 | |
| Daiichi Sankyo INC. | $120.61 | 2021-2022 | |
| Pfizer INC. | $97.27 | 2023-2025 | |
| Evofem Biosciences, INC. | $89.73 | 2021-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $70.50 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $60.72 | 2022-2025 | Slynd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $50.48 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $42.00 | 2020-2021 | |
| Agile Therapeutics, INC. | $39.86 | 2021 | |
| Optumhealth Care Solutions, LLC | $25.44 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Millicent US INC | $24.64 | 2024 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $22.69 | 2019-2021 | |
| Myovant Sciences INC. | $20.97 | 2021 | |
| Exact Sciences Corporation | $20.25 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $19.41 | 2022 | |
| Vertical Pharmaceuticals, LLC | $18.71 | 2019 | |
| Olympus America INC. | $17.95 | 2019 | |
| Lupin INC. | $17.45 | 2020 | |
| Medtronic, INC. | $16.16 | 2022 | |
| Avion Pharmaceuticals | $14.40 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandra Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.